Similarly, treatment of a patient with metastatic melanoma with autologous CD4+ T cells specific for the tumor-associated antigen NY-ESO-1 resulted in sustained clinical remissions with evidence of endogenous immune responses against other tumor-derived antigens (21). Here, CD4 is linked to neoplasm.